Variant report
Variant | esv3406346 |
---|---|
Chromosome Location | chr17:59476220-59479068 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:332)
- CpG islands (count:1466)
- Chromatin interactive region (count:149)
- LncRNA region (count:6)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BACH1 | chr17:59476802-59476913 | H1-hESC | embryonic stem cell: | n/a | n/a |
2 | BACH1 | chr17:59476167-59476317 | H1-hESC | embryonic stem cell: | n/a | n/a |
3 | BRCA1 | chr17:59477044-59477103 | Hela-S3 | cervix: | n/a | chr17:59477047-59477054 |
4 | BRCA1 | chr17:59476468-59476498 | HepG2 | liver: | n/a | n/a |
5 | CEBPB | chr17:59476697-59477251 | Hela-S3 | cervix: | n/a | n/a |
6 | CEBPD | chr17:59476672-59477390 | HepG2 | liver: | n/a | n/a |
7 | CHD2 | chr17:59476301-59477937 | Hela-S3 | cervix: | n/a | n/a |
8 | CHD2 | chr17:59476771-59476909 | HepG2 | liver: | n/a | n/a |
9 | CREB1 | chr17:59476584-59477471 | A549 | lung: | n/a | n/a |
10 | CREB1 | chr17:59475839-59477503 | HepG2 | liver: | n/a | n/a |
11 | CTBP2 | chr17:59478138-59479685 | H1-hESC | embryonic stem cell: | n/a | n/a |
12 | CTBP2 | chr17:59474838-59477174 | H1-hESC | embryonic stem cell: | n/a | n/a |
13 | CTCF | chr17:59476770-59476851 | ProgFib | skin: | n/a | n/a |
14 | CTCF | chr17:59476740-59476890 | HepG2 | liver: | n/a | n/a |
15 | CTCF | chr17:59477100-59477250 | Hela-S3 | cervix: | n/a | n/a |
16 | CTCF | chr17:59476680-59476830 | HEK293 | kidney: | n/a | chr17:59476713-59476726 |
17 | CTCF | chr17:59477840-59477990 | SK-N-SH_RA | brain: | n/a | n/a |
18 | CTCF | chr17:59476755-59476860 | H1-hESC | embryonic stem cell: | n/a | n/a |
19 | CTCF | chr17:59477771-59477937 | MCF-7 | breast: | n/a | n/a |
20 | CTCF | chr17:59477040-59477190 | BJ | skin: | n/a | n/a |
21 | CTCF | chr17:59477000-59477150 | AG09309 | skin: | n/a | n/a |
22 | CTCF | chr17:59476730-59476868 | Hela-S3 | cervix: | n/a | n/a |
23 | CTCF | chr17:59476720-59476870 | Caco-2 | colon: | n/a | n/a |
24 | CTCF | chr17:59476804-59476814 | NHEK | skin: | n/a | n/a |
25 | CTCF | chr17:59477819-59477907 | Fibrobl | skin: | n/a | n/a |
26 | CTCF | chr17:59476640-59476790 | NHDF-neo | bronchial: | n/a | chr17:59476713-59476726 |
27 | CTCF | chr17:59476572-59476909 | HepG2 | liver: | n/a | chr17:59476602-59476615 chr17:59476713-59476726 |
28 | CTCF | chr17:59477040-59477190 | AG04449 | skin: | n/a | n/a |
29 | CTCF | chr17:59476680-59476830 | HPF | lung: | n/a | chr17:59476713-59476726 |
30 | CTCF | chr17:59476760-59476910 | AG09319 | gingival: | n/a | n/a |
31 | CTCF | chr17:59477800-59477923 | A549 | lung: | n/a | n/a |
32 | CTCF | chr17:59477080-59477230 | AG09319 | gingival: | n/a | n/a |
33 | CTCF | chr17:59476755-59477278 | IMR90 | lung: | n/a | n/a |
34 | CTCF | chr17:59476732-59476761 | HepG2 | liver: | n/a | n/a |
35 | CTCF | chr17:59476775-59476839 | MCF-7 | breast: | n/a | n/a |
36 | CTCF | chr17:59476700-59476850 | WERI-Rb-1 | eye: | n/a | chr17:59476713-59476726 |
37 | CTCF | chr17:59477821-59477892 | H1-hESC | embryonic stem cell: | n/a | n/a |
38 | CTCF | chr17:59476540-59476830 | AG04449 | skin: | n/a | chr17:59476564-59476577 chr17:59476602-59476615 chr17:59476713-59476726 |
39 | CTCF | chr17:59478180-59478470 | AG04449 | skin: | n/a | chr17:59478338-59478347 |
40 | CTCF | chr17:59476740-59476890 | AG09319 | gingival: | n/a | n/a |
41 | CTCF | chr17:59477040-59477190 | HBMEC | blood vessel: | n/a | n/a |
42 | CTCF | chr17:59476680-59476830 | WERI-Rb-1 | eye: | n/a | chr17:59476713-59476726 |
43 | CTCF | chr17:59476680-59476830 | SK-N-SH_RA | brain: | n/a | chr17:59476713-59476726 |
44 | CTCF | chr17:59477814-59477907 | MCF-7 | breast: | n/a | n/a |
45 | CTCF | chr17:59476766-59476822 | HepG2 | liver: | n/a | n/a |
46 | CTCF | chr17:59476644-59476832 | T-47D | breast: | n/a | chr17:59476713-59476726 |
47 | CTCF | chr17:59478800-59478950 | HPAF | blood vessel: | n/a | n/a |
48 | CTCF | chr17:59477792-59477919 | MCF-7 | breast: | n/a | n/a |
49 | CTCF | chr17:59477765-59477939 | MCF-7 | breast: | n/a | n/a |
50 | CTCF | chr17:59478880-59479030 | SK-N-SH_RA | brain: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr17:59477146-59477196 | HEEpiC | esophagus: | n/a |
2 | chr17:59478953-59479003 | HRE | kidney: | n/a |
3 | chr17:59477146-59477196 | HEEpiC | esophagus: | n/a |
4 | chr17:59478953-59479003 | HRE | kidney: | n/a |
5 | chr17:59477564-59477614 | HMEC | breast: | n/a |
6 | chr17:59477220-59477270 | HPAEpiC | pulmonary alveolar: | n/a |
7 | chr17:59477203-59477253 | CMK | blood: | n/a |
8 | chr17:59478450-59478500 | PANC-1 | pancreas: | n/a |
9 | chr17:59478953-59479003 | HAEpiC | amniotic membrane: | n/a |
10 | chr17:59477564-59477614 | HCF | heart: | n/a |
11 | chr17:59477172-59477222 | U87 | brain: | n/a |
12 | chr17:59478450-59478500 | HAEpiC | amniotic membrane: | n/a |
13 | chr17:59477019-59477069 | ovcar-3 | ovarian: | n/a |
14 | chr17:59477846-59477896 | SKMC | muscle: | n/a |
15 | chr17:59477203-59477253 | Jurkat | blood: | n/a |
16 | chr17:59478953-59479003 | HEEpiC | esophagus: | n/a |
17 | chr17:59477172-59477222 | MCF-7 | breast: | n/a |
18 | chr17:59476505-59476555 | SK-N-MC | brain: | n/a |
19 | chr17:59478953-59479003 | HMEC | breast: | n/a |
20 | chr17:59478450-59478500 | HCM | heart: | n/a |
21 | chr17:59477027-59477077 | U87 | brain: | n/a |
22 | chr17:59477220-59477270 | AG04450 | lung: | fetal |
23 | chr17:59476859-59476909 | HRPEpiC | eye: | n/a |
24 | chr17:59478953-59479003 | MCF10A-Er-Src | breast: | n/a |
25 | chr17:59476212-59476262 | U87 | brain: | n/a |
26 | chr17:59477027-59477077 | HCM | heart: | n/a |
27 | chr17:59476859-59476909 | HRCEpiC | kidney: | n/a |
28 | chr17:59476334-59476384 | AG09319 | gingival: | n/a |
29 | chr17:59478194-59478244 | HepG2 | liver: | n/a |
30 | chr17:59478068-59478118 | SK-N-SH | brain: | n/a |
31 | chr17:59477027-59477077 | LNCaP | prostate: | n/a |
32 | chr17:59476859-59476909 | NHDF-neo | bronchial: | n/a |
33 | chr17:59477019-59477069 | NHDF-neo | bronchial: | n/a |
34 | chr17:59478579-59478629 | HCF | heart: | n/a |
35 | chr17:59476334-59476384 | HepG2 | liver: | n/a |
36 | chr17:59477286-59477336 | HRE | kidney: | n/a |
37 | chr17:59477112-59477162 | HEK293 | kidney: | embryo |
38 | chr17:59478958-59479008 | LNCaP | prostate: | n/a |
39 | chr17:59477112-59477162 | NB4 | blood: | n/a |
40 | chr17:59477266-59477316 | HAEpiC | amniotic membrane: | n/a |
41 | chr17:59478194-59478244 | GM06990 | blood: | n/a |
42 | chr17:59477081-59477131 | PrEC | prostate: | n/a |
43 | chr17:59478194-59478244 | HRE | kidney: | n/a |
44 | chr17:59478194-59478244 | HL-60 | blood: | n/a |
45 | chr17:59476334-59476384 | NB4 | blood: | n/a |
46 | chr17:59476505-59476555 | ovcar-3 | ovarian: | n/a |
47 | chr17:59476212-59476262 | AG10803 | skin: | n/a |
48 | chr17:59476334-59476384 | AG04450 | lung: | fetal |
49 | chr17:59477286-59477336 | HEK293 | kidney: | embryo |
50 | chr17:59476790-59476840 | NHDF-neo | bronchial: | n/a |
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr17:59468469..59482635-chr20:45977748..45992950,51 | MCF-7 | breast: | |
2 | chr17:59477876..59478765-chr20:49406499..49407614,3 | MCF-7 | breast: | |
3 | chr17:58963859..58966065-chr17:59476840..59479002,2 | MCF-7 | breast: | |
4 | chr17:59476525..59477051-chr17:59486019..59486872,2 | MCF-7 | breast: | |
5 | chr17:59476586..59479504-chr20:45944218..45947716,4 | MCF-7 | breast: | |
6 | chr17:58603002..58605002-chr17:59476396..59478365,2 | MCF-7 | breast: | |
7 | chr17:59474996..59480161-chr20:52556121..52561884,6 | MCF-7 | breast: | |
8 | chr17:59477732..59478309-chr17:59660703..59661411,2 | MCF-7 | breast: | |
9 | chr17:59478017..59478808-chr20:49411353..49411946,2 | MCF-7 | breast: | |
10 | chr17:59475732..59477627-chr6:26249790..26252547,2 | MCF-7 | breast: | |
11 | chr12:1799825..1801584-chr17:59476233..59479039,2 | MCF-7 | breast: | |
12 | chr17:58037859..58039805-chr17:59478183..59480343,2 | MCF-7 | breast: | |
13 | chr17:59476750..59477936-chr20:49410738..49412069,5 | MCF-7 | breast: | |
14 | chr17:59475519..59479534-chr20:45977874..45982127,5 | MCF-7 | breast: | |
15 | chr1:45985941..45987722-chr17:59477306..59479148,2 | MCF-7 | breast: | |
16 | chr17:59476916..59479068-chr4:16227271..16228837,2 | MCF-7 | breast: | |
17 | chr17:57914749..57915447-chr17:59476989..59478273,3 | MCF-7 | breast: | |
18 | chr17:59476469..59479007-chr7:2593916..2596803,2 | MCF-7 | breast: | |
19 | chr17:59475424..59477286-chr9:130741425..130743853,3 | MCF-7 | breast: | |
20 | chr17:59475062..59478026-chr20:39655651..39657666,2 | MCF-7 | breast: | |
21 | chr17:59475970..59478357-chr6:30028344..30030119,2 | MCF-7 | breast: | |
22 | chr17:59476370..59478594-chr2:24298301..24300623,2 | MCF-7 | breast: | |
23 | chr17:59477279..59479183-chr17:59870460..59872520,2 | MCF-7 | breast: | |
24 | chr1:115299188..115301953-chr17:59475325..59477891,2 | MCF-7 | breast: | |
25 | chr14:59950680..59952584-chr17:59476205..59479170,2 | MCF-7 | breast: | |
26 | chr17:59476079..59477930-chr2:25194673..25196791,2 | MCF-7 | breast: | |
27 | chr17:59476812..59478629-chr19:33071471..33073536,2 | MCF-7 | breast: | |
28 | chr17:56707939..56709505-chr17:59478696..59480864,2 | MCF-7 | breast: | |
29 | chr17:59476722..59478880-chr17:73780911..73783246,2 | MCF-7 | breast: | |
30 | chr17:59475462..59478386-chr17:59485811..59488031,27 | MCF-7 | breast: | |
31 | chr17:59478442..59480320-chr2:227663816..227665961,2 | MCF-7 | breast: | |
32 | chr17:59476138..59477780-chr3:64007387..64010093,2 | MCF-7 | breast: | |
33 | chr17:59476206..59478986-chr17:59937418..59941494,6 | MCF-7 | breast: | |
34 | chr11:65190161..65193929-chr17:59476956..59480011,3 | MCF-7 | breast: | |
35 | chr10:101379177..101382119-chr17:59476299..59478201,2 | MCF-7 | breast: | |
36 | chr15:71407064..71409343-chr17:59476860..59479120,2 | MCF-7 | breast: | |
37 | chr17:56735328..56738474-chr17:59474554..59477882,3 | MCF-7 | breast: | |
38 | chr17:59477651..59479888-chr6:89671941..89673981,2 | MCF-7 | breast: | |
39 | chr17:59476933..59478370-chr20:49410741..49412054,5 | MCF-7 | breast: | |
40 | chr17:59477427..59479626-chr17:59488065..59490134,11 | MCF-7 | breast: | |
41 | chr17:59474707..59482954-chr20:45984179..45991970,21 | MCF-7 | breast: | |
42 | chr17:59477552..59479078-chr6:32935128..32937807,2 | MCF-7 | breast: | |
43 | chr16:2199599..2201904-chr17:59476660..59478915,2 | MCF-7 | breast: | |
44 | chr17:57183794..57185492-chr17:59476524..59479346,2 | MCF-7 | breast: | |
45 | chr17:59477261..59479812-chr7:115849436..115851792,2 | MCF-7 | breast: | |
46 | chr17:59475836..59478140-chr4:140476860..140478447,2 | MCF-7 | breast: | |
47 | chr17:59474584..59479937-chr20:48725175..48731303,15 | MCF-7 | breast: | |
48 | chr17:59475016..59476729-chr20:52744400..52746392,3 | MCF-7 | breast: | |
49 | chr17:59474806..59476625-chr20:45952325..45954031,2 | MCF-7 | breast: | |
50 | chr17:59447417..59500105-chr20:49391742..49424382,639 | MCF-7 | breast: |
(count:6 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-NACA2-2 | chr17:59476600-59476949 | ENSG00000267280.1 |
2 | lnc-NACA2-2 | chr17:59476398-59477096 | XLOC_012542 |
3 | lnc-NACA2-5 | chr17:59477577-59477604 | ENSG00000267131.1 |
4 | lnc-NACA2-2 | chr17:59476600-59476780 | XLOC_012542 |
5 | lnc-NACA2-2 | chr17:59476600-59476731 | ENSG00000267280.1 |
6 | lnc-NACA2-2 | chr17:59476398-59476967 | ENSG00000267280.1 |
No data |
No data |
Variant related genes | Relation type |
---|---|
TBX2 | TF binding region |
ENSG00000267131 | TF binding region |
ENSG00000267280 | TF binding region |
TBX2 | CpG island |
ENSG00000267131 | CpG island |
ENSG00000267280 | CpG island |
ENSG00000272953 | chromatin interactions |
ENSG00000263327 | chromatin interactions |
ENSG00000196866 | chromatin interactions |
ENSG00000244687 | chromatin interactions |
ENSG00000266163 | chromatin interactions |
ENSG00000178149 | chromatin interactions |
ENSG00000223725 | chromatin interactions |
ENSG00000139718 | chromatin interactions |
ENSG00000267280 | chromatin interactions |
ENSG00000116489 | chromatin interactions |
ENSG00000170525 | chromatin interactions |
ENSG00000111206 | chromatin interactions |
ENSG00000115677 | chromatin interactions |
ENSG00000244300 | chromatin interactions |
ENSG00000264063 | chromatin interactions |
ENSG00000199004 | chromatin interactions |
ENSG00000083307 | chromatin interactions |
ENSG00000185278 | chromatin interactions |
ENSG00000006831 | chromatin interactions |
ENSG00000207605 | chromatin interactions |
ENSG00000204623 | chromatin interactions |
ENSG00000231437 | chromatin interactions |
ENSG00000158805 | chromatin interactions |
ENSG00000259349 | chromatin interactions |
ENSG00000145391 | chromatin interactions |
ENSG00000226308 | chromatin interactions |
ENSG00000127838 | chromatin interactions |
ENSG00000167106 | chromatin interactions |
ENSG00000136492 | chromatin interactions |
ENSG00000236352 | chromatin interactions |
ENSG00000184402 | chromatin interactions |
ENSG00000126790 | chromatin interactions |
ENSG00000062716 | chromatin interactions |
ENSG00000198162 | chromatin interactions |
ENSG00000197409 | chromatin interactions |
ENSG00000172939 | chromatin interactions |
ENSG00000174136 | chromatin interactions |
ENSG00000163349 | chromatin interactions |
ENSG00000105185 | chromatin interactions |
ENSG00000273451 | chromatin interactions |
ENSG00000111880 | chromatin interactions |
ENSG00000223247 | chromatin interactions |
ENSG00000171940 | chromatin interactions |
ENSG00000041357 | chromatin interactions |
ENSG00000213614 | chromatin interactions |
ENSG00000171385 | chromatin interactions |
ENSG00000264462 | chromatin interactions |
ENSG00000260339 | chromatin interactions |
ENSG00000062650 | chromatin interactions |
ENSG00000144401 | chromatin interactions |
ENSG00000184825 | chromatin interactions |
ENSG00000077454 | chromatin interactions |
ENSG00000163636 | chromatin interactions |
ENSG00000132478 | chromatin interactions |
ENSG00000258947 | chromatin interactions |
ENSG00000065357 | chromatin interactions |
ENSG00000224165 | chromatin interactions |
ENSG00000124126 | chromatin interactions |
ENSG00000110700 | chromatin interactions |
ENSG00000169047 | chromatin interactions |
ENSG00000137259 | chromatin interactions |
ENSG00000204257 | chromatin interactions |
ENSG00000106009 | chromatin interactions |
ENSG00000130703 | chromatin interactions |
ENSG00000124693 | chromatin interactions |
ENSG00000124243 | chromatin interactions |
ENSG00000199032 | chromatin interactions |
ENSG00000115137 | chromatin interactions |
ENSG00000153107 | chromatin interactions |
ENSG00000197903 | chromatin interactions |
ENSG00000196420 | chromatin interactions |
ENSG00000141376 | chromatin interactions |
ENSG00000121068 | chromatin interactions |
ENSG00000201524 | chromatin interactions |
ENSG00000115128 | chromatin interactions |
ENSG00000133316 | chromatin interactions |
ENSG00000260475 | chromatin interactions |
ENSG00000198900 | chromatin interactions |
ENSG00000117450 | chromatin interactions |
ENSG00000212694 | chromatin interactions |
ENSG00000103342 | chromatin interactions |
ENSG00000062725 | chromatin interactions |
ENSG00000254772 | chromatin interactions |
ENSG00000202077 | chromatin interactions |
ENSG00000068650 | chromatin interactions |
ENSG00000075399 | chromatin interactions |
ENSG00000139725 | chromatin interactions |
ENSG00000125520 | chromatin interactions |
ENSG00000254024 | chromatin interactions |
ENSG00000178057 | chromatin interactions |
ENSG00000143811 | chromatin interactions |
ENSG00000066379 | chromatin interactions |
ENSG00000224532 | chromatin interactions |
ENSG00000256316 | chromatin interactions |
ENSG00000178096 | chromatin interactions |
ENSG00000224738 | chromatin interactions |
ENSG00000176105 | chromatin interactions |
ENSG00000135269 | chromatin interactions |
ENSG00000184270 | chromatin interactions |
ENSG00000226155 | chromatin interactions |
ENSG00000122692 | chromatin interactions |
ENSG00000272622 | chromatin interactions |
ENSG00000171792 | chromatin interactions |
ENSG00000182095 | chromatin interactions |
ENSG00000101040 | chromatin interactions |
ENSG00000175895 | chromatin interactions |
ENSG00000167964 | chromatin interactions |
ENSG00000118260 | chromatin interactions |
ENSG00000050130 | chromatin interactions |
ENSG00000179348 | chromatin interactions |
ENSG00000197846 | chromatin interactions |
ENSG00000167685 | chromatin interactions |
ENSG00000132475 | chromatin interactions |
ENSG00000124171 | chromatin interactions |
ENSG00000177169 | chromatin interactions |
ENSG00000155287 | chromatin interactions |
ENSG00000106336 | chromatin interactions |
ENSG00000169762 | chromatin interactions |
ENSG00000009307 | chromatin interactions |
ENSG00000200156 | chromatin interactions |
ENSG00000225362 | chromatin interactions |
ENSG00000124151 | chromatin interactions |
ENSG00000272717 | chromatin interactions |
ENSG00000197459 | chromatin interactions |
ENSG00000170473 | chromatin interactions |
ENSG00000235527 | chromatin interactions |
ENSG00000259006 | chromatin interactions |
ENSG00000212195 | chromatin interactions |
ENSG00000155506 | chromatin interactions |
ENSG00000234741 | chromatin interactions |
ENSG00000227896 | chromatin interactions |
ENSG00000197451 | chromatin interactions |
ENSG00000007341 | chromatin interactions |
ENSG00000061938 | chromatin interactions |
ENSG00000038382 | chromatin interactions |
ENSG00000101144 | chromatin interactions |
ENSG00000231119 | chromatin interactions |
ENSG00000219626 | chromatin interactions |
ENSG00000108395 | chromatin interactions |
ENSG00000119397 | chromatin interactions |
ENSG00000101182 | chromatin interactions |
ENSG00000078246 | chromatin interactions |
ENSG00000172137 | chromatin interactions |
ENSG00000245532 | chromatin interactions |
ENSG00000136950 | chromatin interactions |
ENSG00000187013 | chromatin interactions |
ENSG00000184260 | chromatin interactions |
ENSG00000273355 | chromatin interactions |
ENSG00000267882 | chromatin interactions |
ENSG00000170836 | chromatin interactions |
ENSG00000246763 | chromatin interactions |
ENSG00000204256 | chromatin interactions |
ENSG00000199787 | chromatin interactions |
KLHL3 | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs568560613 | chr17:59476235-59476236 | Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Flanking Active TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive region | 84 gene(s) | Overlapped CNVs | n/a |
2 | rs370423794 | chr17:59476275-59476276 | Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Flanking Active TSS Transcr. at gene 5' and 3' | TF binding regionChromatin interactive region | 86 gene(s) | Overlapped CNVs | n/a |
3 | rs534222365 | chr17:59476277-59476278 | Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Flanking Active TSS Transcr. at gene 5' and 3' | TF binding regionChromatin interactive region | 86 gene(s) | Overlapped CNVs | n/a |
4 | rs183889790 | chr17:59476295-59476296 | Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Flanking Active TSS Transcr. at gene 5' and 3' | TF binding regionChromatin interactive region | 86 gene(s) | Overlapped CNVs | n/a |
5 | rs113372673 | chr17:59476301-59476302 | Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Flanking Active TSS Transcr. at gene 5' and 3' | TF binding regionChromatin interactive region | 88 gene(s) | Overlapped CNVs | n/a |
6 | rs569550085 | chr17:59476307-59476308 | Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Flanking Active TSS Transcr. at gene 5' and 3' | TF binding regionChromatin interactive region | 88 gene(s) | Overlapped CNVs | n/a |
7 | rs73991913 | chr17:59476316-59476317 | Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Flanking Active TSS Transcr. at gene 5' and 3' | TF binding regionChromatin interactive region | 93 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs1476781 | chr17:59476415-59476416 | Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers Weak transcription | TF binding regionChromatin interactive regionlncRNA | 102 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs9913766 | chr17:59476431-59476432 | Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers Weak transcription | TF binding regionChromatin interactive regionlncRNA | 103 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs570530681 | chr17:59476463-59476464 | Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers Weak transcription | TF binding regionChromatin interactive regionlncRNA | 103 gene(s) | Overlapped CNVs | n/a |
11 | rs570274868 | chr17:59476478-59476479 | Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers Weak transcription | TF binding regionChromatin interactive regionlncRNA | 105 gene(s) | Overlapped CNVs | n/a |
12 | rs535659400 | chr17:59476492-59476493 | Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers Weak transcription | TF binding regionChromatin interactive regionlncRNA | 105 gene(s) | Overlapped CNVs | n/a |
13 | rs544478185 | chr17:59476506-59476507 | Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers Weak transcription | TF binding regionCpG islandChromatin interactive regionlncRNA | 105 gene(s) | Overlapped CNVs | n/a |
14 | rs4455026 | chr17:59476510-59476511 | Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers Weak transcription | TF binding regionCpG islandChromatin interactive regionlncRNA | 105 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs539862445 | chr17:59476556-59476557 | Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers Weak transcription | TF binding regionChromatin interactive regionlncRNA | 112 gene(s) | Overlapped CNVs | n/a |
16 | rs553315564 | chr17:59476581-59476582 | Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers Weak transcription | TF binding regionChromatin interactive regionlncRNA | 112 gene(s) | Overlapped CNVs | n/a |
17 | rs140176607 | chr17:59476583-59476584 | Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers Weak transcription | TF binding regionChromatin interactive regionlncRNA | 112 gene(s) | Overlapped CNVs | n/a |
18 | rs546032616 | chr17:59476639-59476640 | Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Weak transcription | TF binding regionChromatin interactive regionlncRNA | 114 gene(s) | Overlapped CNVs | n/a |
19 | rs188207072 | chr17:59476695-59476696 | Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Weak transcription | TF binding regionChromatin interactive regionlncRNA | 116 gene(s) | Overlapped CNVs | n/a |
20 | rs562783686 | chr17:59476722-59476723 | Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Weak transcription | TF binding regionChromatin interactive regionlncRNA | 118 gene(s) | Overlapped CNVs | n/a |
21 | rs542033810 | chr17:59476736-59476737 | Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Weak transcription | TF binding regionChromatin interactive regionlncRNA | 119 gene(s) | Overlapped CNVs | n/a |
22 | rs562195316 | chr17:59476771-59476772 | Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Weak transcription | TF binding regionChromatin interactive regionlncRNA | 118 gene(s) | Overlapped CNVs | n/a |
23 | rs527759939 | chr17:59476791-59476792 | Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Weak transcription | TF binding regionCpG islandChromatin interactive regionlncRNA | 118 gene(s) | Overlapped CNVs | n/a |
24 | rs547830194 | chr17:59476856-59476857 | Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Weak transcription | TF binding regionChromatin interactive regionlncRNA | 120 gene(s) | Overlapped CNVs | n/a |
25 | rs570777008 | chr17:59476860-59476861 | Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Weak transcription | TF binding regionCpG islandChromatin interactive regionlncRNA | 121 gene(s) | Overlapped CNVs | n/a |
26 | rs2286524 | chr17:59476892-59476893 | Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Weak transcription | TF binding regionCpG islandChromatin interactive regionlncRNA | 120 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs550488858 | chr17:59476929-59476930 | Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Weak transcription | TF binding regionChromatin interactive regionlncRNA | 123 gene(s) | Overlapped CNVs | n/a |
28 | rs577702577 | chr17:59476946-59476947 | Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Weak transcription | TF binding regionChromatin interactive regionlncRNA | 123 gene(s) | Overlapped CNVs | n/a |
29 | rs535680738 | chr17:59476957-59476958 | Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Weak transcription | TF binding regionChromatin interactive regionlncRNA | 124 gene(s) | Overlapped CNVs | n/a |
30 | rs555512138 | chr17:59476959-59476960 | Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Weak transcription | TF binding regionChromatin interactive regionlncRNA | 124 gene(s) | Overlapped CNVs | n/a |
31 | rs567829853 | chr17:59476983-59476984 | Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Weak transcription | TF binding regionChromatin interactive regionlncRNA | 125 gene(s) | Overlapped CNVs | n/a |
32 | rs545126163 | chr17:59477013-59477014 | Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS | TF binding regionChromatin interactive regionlncRNA | 125 gene(s) | Overlapped CNVs | n/a |
33 | rs533600655 | chr17:59477100-59477101 | Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS | TF binding regionCpG islandChromatin interactive region | 126 gene(s) | Overlapped CNVs | n/a |
34 | rs553493970 | chr17:59477103-59477104 | Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS | TF binding regionCpG islandChromatin interactive region | 126 gene(s) | Overlapped CNVs | n/a |
35 | rs576819971 | chr17:59477112-59477113 | Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS | TF binding regionCpG islandChromatin interactive region | 126 gene(s) | Overlapped CNVs | n/a |
36 | rs545473916 | chr17:59477144-59477145 | Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS | TF binding regionCpG islandChromatin interactive region | 127 gene(s) | Overlapped CNVs | n/a |
37 | rs556456024 | chr17:59477167-59477168 | Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS | TF binding regionCpG islandChromatin interactive region | 130 gene(s) | Overlapped CNVs | n/a |
38 | rs576238252 | chr17:59477241-59477242 | Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Weak transcription | TF binding regionCpG islandChromatin interactive region | 134 gene(s) | Overlapped CNVs | n/a |
39 | rs542070549 | chr17:59477270-59477271 | Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Weak transcription | TF binding regionCpG islandChromatin interactive region | 135 gene(s) | Overlapped CNVs | n/a |
40 | rs561833087 | chr17:59477357-59477358 | Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Weak transcription | TF binding regionChromatin interactive region | 136 gene(s) | Overlapped CNVs | n/a |
41 | rs113313819 | chr17:59477412-59477413 | Bivalent/Poised TSS Active TSS Enhancers Bivalent Enhancer Weak transcription | TF binding regionChromatin interactive region | 136 gene(s) | Overlapped CNVs | n/a |
42 | rs113187885 | chr17:59477413-59477414 | Bivalent/Poised TSS Active TSS Enhancers Bivalent Enhancer Weak transcription | TF binding regionChromatin interactive region | 136 gene(s) | Overlapped CNVs | n/a |
43 | rs527788664 | chr17:59477515-59477516 | Bivalent/Poised TSS Active TSS Enhancers Bivalent Enhancer Weak transcription | TF binding regionChromatin interactive region | 134 gene(s) | Overlapped CNVs | n/a |
44 | rs112990883 | chr17:59477523-59477524 | Bivalent/Poised TSS Active TSS Enhancers Bivalent Enhancer Weak transcription | TF binding regionChromatin interactive region | 134 gene(s) | Overlapped CNVs | n/a |
45 | rs1057976 | chr17:59477556-59477557 | Bivalent/Poised TSS Active TSS Enhancers Bivalent Enhancer Weak transcription | TF binding regionChromatin interactive region | 133 gene(s) | Overlapped CNVs | n/a |
46 | rs372758653 | chr17:59477636-59477637 | Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription | TF binding regionChromatin interactive region | 135 gene(s) | Overlapped CNVs | n/a |
47 | rs539663160 | chr17:59477723-59477724 | Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription | TF binding regionChromatin interactive region | 135 gene(s) | Overlapped CNVs | n/a |
48 | rs564411433 | chr17:59477737-59477738 | Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription | TF binding regionChromatin interactive region | 134 gene(s) | Overlapped CNVs | n/a |
49 | rs533394938 | chr17:59477743-59477744 | Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription | TF binding regionChromatin interactive region | 134 gene(s) | Overlapped CNVs | n/a |
50 | rs549885020 | chr17:59477765-59477766 | Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription | TF binding regionChromatin interactive region | 136 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Melanoma | 18172304 | CNVD |
Moyamoya disease | 22323933 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chordoma | 21602918 | CNVD |
Neurofibromatosis | 20686819 | CNVD |
Peripheral nerve sheath tumors | 20686819 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Breast cancer | 21264507 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute myeloid leukemia | 20724749 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Gastric cancer | 17167181 | CNVD |
Breast cancer | 19287154 | CNVD |
Leukemia | 20874852 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 20953835 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Bladder cancer | 21909424 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Ewing''s sarcoma | 18628472 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21364760 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Breast cancer | 21509527 | CNVD |
Chordoma | 18071362 | CNVD |
Cancer | 16751803 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 21523713 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 21785460 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 21467264 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Breast cancer | 16397240 | CNVD |
Breast cancer | 17603634 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Breast cancer | 16608533 | CNVD |
Breast cancer | 21858162 | CNVD |
Neurocytoma | 17123091 | CNVD |
Central neurocytomas | 17123091 | CNVD |
XY sex reversal | 17503084 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Sensorineural hearing loss | 22052739 | CNVD |
intellectual deficit | 22052739 | CNVD |
no characteristic dysmorphism | 22052739 | CNVD |
speech delay | 22052739 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17899364 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Myelofibrosis | 22110671 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Breast cancer | 16620391 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Autism | 22102821 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:59473400-59476400 | Bivalent Enhancer | Brain Germinal Matrix | brain |
2 | chr17:59473400-59477000 | Bivalent Enhancer | Primary B cells from peripheral blood | blood |
3 | chr17:59473400-59479800 | Bivalent Enhancer | Primary T cells fromperipheralblood | blood |
4 | chr17:59473600-59476400 | Bivalent Enhancer | Primary T helper cells PMA-I stimulated | -- |
5 | chr17:59473600-59477400 | Bivalent Enhancer | Primary T helper memory cells from peripheral blood 1 | blood |
6 | chr17:59474200-59476400 | Bivalent Enhancer | Primary Natural Killer cells fromperipheralblood | blood |
7 | chr17:59474200-59479000 | Active TSS | Aorta | Aorta |
8 | chr17:59474200-59481000 | Active TSS | NHDF-Ad | bronchial |
9 | chr17:59474400-59479800 | Bivalent/Poised TSS | iPS-15b Cell Line | embryonic stem cell |
10 | chr17:59474600-59476400 | Bivalent Enhancer | ES-UCSF4 Cell Line | embryonic stem cell |
11 | chr17:59474800-59476400 | Flanking Active TSS | Ganglion Eminence derived primary cultured neurospheres | brain |
12 | chr17:59474800-59476600 | Flanking Bivalent TSS/Enh | Fetal Muscle Trunk | muscle |
13 | chr17:59474800-59476600 | Flanking Bivalent TSS/Enh | Fetal Stomach | stomach |
14 | chr17:59474800-59476800 | Flanking Bivalent TSS/Enh | Fetal Muscle Leg | muscle |
15 | chr17:59474800-59477200 | Bivalent Enhancer | Primary T helper 17 cells PMA-I stimulated | -- |
16 | chr17:59474800-59477200 | Bivalent Enhancer | Primary T killer naive cells fromperipheralblood | blood |
17 | chr17:59474800-59477200 | Flanking Bivalent TSS/Enh | Cortex derived primary cultured neurospheres | brain |
18 | chr17:59474800-59477200 | Flanking Bivalent TSS/Enh | Skeletal Muscle Male | skeletal muscle |
19 | chr17:59474800-59477400 | Flanking Bivalent TSS/Enh | Fetal Adrenal Gland | Adrenal Gland |
20 | chr17:59475000-59476400 | Flanking Bivalent TSS/Enh | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
21 | chr17:59475000-59476400 | Bivalent Enhancer | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
22 | chr17:59475000-59476400 | Bivalent Enhancer | Primary T helper memory cells from peripheral blood 2 | blood |
23 | chr17:59475000-59476400 | Flanking Active TSS | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
24 | chr17:59475000-59476400 | Bivalent/Poised TSS | Rectal Mucosa Donor 31 | rectum |
25 | chr17:59475000-59476400 | Transcr. at gene 5' and 3' | NHLF | lung |
26 | chr17:59475000-59479200 | Active TSS | HSMM | muscle |
27 | chr17:59475000-59480400 | Bivalent/Poised TSS | Fetal Intestine Small | intestine |
28 | chr17:59475200-59476400 | Bivalent Enhancer | ES-WA7 Cell Line | embryonic stem cell |
29 | chr17:59475200-59476600 | Flanking Bivalent TSS/Enh | Placenta | Placenta |
30 | chr17:59475400-59476400 | Bivalent Enhancer | iPS DF 6.9 Cell Line | embryonic stem cell |
31 | chr17:59475400-59476400 | Enhancers | Primary T helper naive cells from peripheral blood | blood |
32 | chr17:59475400-59476400 | Flanking Bivalent TSS/Enh | Left Ventricle | heart |
33 | chr17:59475400-59476400 | Flanking Bivalent TSS/Enh | Skeletal Muscle Female | skeletal muscle |
34 | chr17:59475400-59476600 | Flanking Active TSS | Right Atrium | heart |
35 | chr17:59475400-59476800 | Flanking Bivalent TSS/Enh | Esophagus | oesophagus |
36 | chr17:59475400-59476800 | Flanking Bivalent TSS/Enh | NH-A | brain |
37 | chr17:59475400-59478800 | Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
38 | chr17:59475400-59479600 | Bivalent/Poised TSS | Rectal Smooth Muscle | rectum |
39 | chr17:59475600-59476400 | Bivalent Enhancer | Primary hematopoietic stem cells | blood |
40 | chr17:59475600-59476400 | Bivalent/Poised TSS | Rectal Mucosa Donor 29 | rectum |
41 | chr17:59475600-59476400 | Flanking Active TSS | Right Ventricle | heart |
42 | chr17:59475600-59476600 | Bivalent Enhancer | Brain Inferior Temporal Lobe | brain |
43 | chr17:59475600-59476600 | Bivalent Enhancer | Fetal Thymus | thymus |
44 | chr17:59475600-59477000 | Bivalent Enhancer | Primary T regulatory cells fromperipheralblood | blood |
45 | chr17:59475600-59477000 | Flanking Bivalent TSS/Enh | Brain Hippocampus Middle | brain |
46 | chr17:59475800-59476400 | Flanking Bivalent TSS/Enh | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
47 | chr17:59475800-59476400 | Bivalent Enhancer | Primary T killer memory cells from peripheral blood | blood |
48 | chr17:59475800-59476400 | Active TSS | Foreskin Melanocyte Primary Cells skin01 | Skin |
49 | chr17:59475800-59476400 | Bivalent/Poised TSS | Brain Anterior Caudate | brain |
50 | chr17:59475800-59476400 | Flanking Bivalent TSS/Enh | HepG2 | liver |